| Date Filed | Type | Description |
| 08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/03/2023 |
8-K
| Quarterly results |
| 07/13/2023 |
4
| Smith Michael Alexander (General Counsel, Senior VP) has filed a Form 4 on INSMED Inc|
Txns:
| Sold 740 shares
@ $20.18, valued at
$14.9k
|
|
| 07/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/07/2023 |
8-K/A
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/19/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 05/19/2023 |
S-3ASR
| Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers: |
| 05/17/2023 |
4
| Wise John Drayton (Chief Commercial Officer) has filed a Form 4 on INSMED Inc|
Txns:
| Sold 593 shares
@ $19.29, valued at
$11.4k
Sold 381 shares
@ $18.44, valued at
$7k
Sold 1,913 shares
@ $18.17, valued at
$34.8k
|
|
| 05/17/2023 |
4
| Smith Michael Alexander (General Counsel, Senior VP) has filed a Form 4 on INSMED Inc|
Txns:
| Sold 1,897 shares
@ $19.24, valued at
$36.5k
Sold 475 shares
@ $18.43, valued at
$8.8k
Sold 1,263 shares
@ $18.18, valued at
$23k
|
|
| 05/17/2023 |
4
| Schaeffer Orlov S Nicole (Chief People Strategy Officer) has filed a Form 4 on INSMED Inc|
Txns:
| Sold 1,830 shares
@ $19.22, valued at
$35.2k
Sold 1,217 shares
@ $18.45, valued at
$22.5k
Sold 1,972 shares
@ $18.16, valued at
$35.8k
|
|
| 05/17/2023 |
4
| Lewis William (Chair and CEO) has filed a Form 4 on INSMED Inc|
Txns:
| Sold 6,048 shares
@ $19.23, valued at
$116.3k
Sold 3,714 shares
@ $18.41, valued at
$68.4k
Sold 7,099 shares
@ $18.12, valued at
$128.6k
|
|
| 05/17/2023 |
4
| Flammer Martina M.D. (Chief Medical Officer) has filed a Form 4 on INSMED Inc|
Txns:
| Sold 2,576 shares
@ $19.28, valued at
$49.7k
Sold 1,718 shares
@ $18.43, valued at
$31.7k
|
|
| 05/17/2023 |
4
| Bonstein Sara (CFO) has filed a Form 4 on INSMED Inc|
Txns:
| Sold 2,210 shares
@ $19.3, valued at
$42.7k
Sold 1,610 shares
@ $18.47, valued at
$29.7k
|
|
| 05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/11/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/08/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/04/2023 |
8-K
| Quarterly results |
| 03/31/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 03/31/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/17/2023 |
4
| SHAROKY MELVIN MD (Director) has filed a Form 4 on INSMED Inc|
Txns:
| Gifted 3,798 shares
@ $0 |
|
| 02/23/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/23/2023 |
8-K
| Quarterly results |
| 02/14/2023 |
SC 13G
| T. Rowe Price Investment Management, Inc. reports a 6.2% stake in INSMED INC |
| 02/14/2023 |
SC 13G/A
| PRICE T ROWE ASSOCIATES INC reports a 7.4% stake in INSMED INC |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 9.6% stake in Insmed Inc. |
| 02/09/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/03/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|